(Q24202824)

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

High dose zinc increases hospital admissions due to genitourinary complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

Effects of long-term zinc supplementation on plasma thiol metabolites and redox status in patients with age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

A randomised controlled trial investigating the effect of nutritional supplementation on visual function in normal, and age-related macular disease affected eyes: design and methodology [ISRCTN78467674]

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

Carotenoids in Age-related Maculopathy Italian Study (CARMIS): two-year results of a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

A randomized, prospective, placebo-controlled clinical trial of a novel zinc-monocysteine compound in age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

Methodology of the VECAT study: vitamin E intervention in cataract and age-related maculopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

Community-based recruitment strategies for a longitudinal interventional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

Baseline ophthalmic findings in the vitamin E, cataract and age-related maculopathy (VECAT) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

The VECAT study: methodology and statistical power for measurement of age-related macular features. Vitamin E, Cataract, and Age-related Maculopathy Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

LAST II: Differential temporal responses of macular pigment optical density in patients with atrophic age-related macular degeneration to dietary supplementation with xanthophylls

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

Lutein supplementation in retinitis pigmentosa: PC-based vision assessment in a randomized double-masked placebo-controlled clinical trial [NCT00029289].

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

Enhanced bioavailability of zeaxanthin in a milk-based formulation of wolfberry (Gou Qi Zi; Fructus barbarum L.).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

Macular pigment response to a supplement containing meso-zeaxanthin, lutein and zeaxanthin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

TOZAL Study: an open case control study of an oral antioxidant and omega-3 supplement for dry AMD

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

Beta carotene supplementation and age-related maculopathy in a randomized trial of US physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

Supplementation with all three macular carotenoids: response, stability, and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

Plasma homocysteine, vitamin B12 and folate levels in age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

The effect of lutein and zeaxanthin supplementation on metabolites of these carotenoids in the serum of persons aged 60 or older.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

One-year results of a pilot study using oral 13-cis retinoic acid as a treatment for subfoveal predominantly occult choroidal neovascularization in patients with age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

Supplementation with the carotenoids lutein or zeaxanthin improves human visual performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

The effects of supplementation with lutein and/or zeaxanthin on human macular pigment density and colour vision.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

Xanthophyll accumulation in the human retina during supplementation with lutein or zeaxanthin - the LUXEA (LUtein Xanthophyll Eye Accumulation) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

Monthly consistency of macular pigment optical density and serum concentrations of lutein and zeaxanthin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

Risk factors for age-related maculopathy are associated with a relative lack of macular pigment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

Macular carotenoid supplementation in subjects with atypical spatial profiles of macular pigment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

Vitamin E in the treatment of uveitis-associated macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

Vitamins E and C and medical record-confirmed age-related macular degeneration in a randomized trial of male physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

Treatment of geographic atrophy by the topical administration of OT-551: results of a phase II clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

Carotenoids and co-antioxidants in age-related maculopathy: design and methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

Influence of saffron supplementation on retinal flicker sensitivity in early age-related macular degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

Brightness, contrast, and color balance of digital versus film retinal images in the age-related eye disease study 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

The Grading and Prevalence of Macular Degeneration in Chesapeake Bay Watermen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

Causes of blind and partial sight certifications in England and Wales: April 2007-March 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

Antioxidants and age-related eye disease. Current and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

Yellow corneal ring associated with vitamin supplementation for age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

The efficacy and safety of multivitamin and mineral supplement use to prevent cancer and chronic disease in adults: a systematic review for a National Institutes of Health state-of-the-science conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

The Wisconsin age-related maculopathy grading system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

The estimated prevalence and incidence of late stage age related macular degeneration in the UK

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

Dose-Ranging Study of Lutein Supplementation in Persons Aged 60 Years or Older

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

Associations Between Intermediate Age-Related Macular Degeneration and Lutein and Zeaxanthin in the Carotenoids in Age-Related Eye Disease Study (CAREDS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

7 January 2021

Oral zinc in macular degeneration

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

7 January 2021

Effect of 1-year lutein supplementation on macular pigment optical density and visual function

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

7 January 2021

Prevalence of age-related maculopathy. The Beaver Dam Eye Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

7 January 2021

Community-based recruitment strategies for a longitudinal interventional study: the VECAT experience

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

7 January 2021

Spinach cultigen variation for tissue carotenoid concentrations influences human serum carotenoid levels and macular pigment optical density following a 12-week dietary intervention

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

7 January 2021

Effect of lutein and antioxidant dietary supplementation on contrast sensitivity in age-related macular disease: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

7 January 2021

[Changes of macular pigment and drusen morphology in patients with lutein supplementation]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

7 January 2021

Effect of niacin on retinal vascular diameter in patients with age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

7 January 2021

Effect of dietary lutein and zeaxanthin on plasma carotenoids and their transport in lipoproteins in age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

7 January 2021

Consumption of one egg per day increases serum lutein and zeaxanthin concentrations in older adults without altering serum lipid and lipoprotein cholesterol concentrations

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

7 January 2021

A 12-wk egg intervention increases serum zeaxanthin and macular pigment optical density in women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

7 January 2021

Functional and morphologic benefits in early detection of neovascular age-related macular degeneration using the preferential hyperacuity perimeter

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

7 January 2021

On the treatment of arteriosclerotic chorioretinopathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

7 January 2021

Visaline in the treatment of age-related macular degeneration: a pilot study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

7 January 2021

Effect of short-term, high-dose retinol on dark adaptation in aging and early age-related maculopathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

7 January 2021

Effects of Lutein Supplementation on Macular Pigment Optical Density and Visual Acuity in Patients with Age-Related Macular Degeneration

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB3

7 January 2021

10.1002/14651858.CD000254.PUB3

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2445403

Fatcat ID

release_e6h5d4ap5bdl7pn656nxrzbxaq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/e6h5d4ap5bdl7pn656nxrzbxaq

24 November 2022

mapped directly with Wikidata item

OpenCitations bibliographic resource ID

2445403

1 reference